CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Akers Biosciences Inc 's Quick Ratio

AKER's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




AKER Quick Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Current Liabilities Change 83.19 % 62.3 % 4.99 % -22.48 % -40.34 %
Y / Y Cash & cash equivalent Change 620.55 % 328.76 % 56.57 % 77.49 % -47.98 %
Quick Ratio MRQ 9.19 6.97 3.41 6.33 2.34
Overall Ranking # # # # #
Seq. Current Liabilities Change -4.21 % 20.44 % 42.5 % 11.42 % -15.13 %
Seq. Cash & cash equivalent Change 26.31 % 145.95 % -23.13 % 201.75 % -24.84 %



Quick Ratio third quarter 2020 Comment
Akers Biosciences Inc 's Cash & cash equivalent grew by 26.31 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Akers Biosciences Inc 's Quick Ratio to 9.19, Quick Ratio remained below Akers Biosciences Inc average.

Within Biotechnology & Drugs industry 58 other companies have achieved higher Quick Ratio than Akers Biosciences Inc in third quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AKER Segments?
See Quick Ratio AKER on the trailing twelve month basis
Quick Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 59
Healthcare Sector # 185
Overall Market # 395


Quick Ratio Statistics
High Average Low
13.57 4.48 0.07
(Mar 31 2014)   (Dec 31 2016)




Financial Statements
Akers Biosciences Inc 's Current Liabilities $ 3 Millions Visit AKER's Balance sheet
Akers Biosciences Inc 's Cash & cash equivalent $ 23 Millions Visit AKER's Balance sheet
Source of AKER's Sales Visit AKER's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Quick RatioSep 30 2020 MRQ Cash & cash equivalentSep 30 2020 MRQ Current Liabilities
Riot Blockchain Inc   23.88 $ 30.086  Millions$ 1.260  Millions
Oyster Point Pharma Inc   23.71 $ 214.331  Millions$ 9.038  Millions
Acceleron Pharma inc  23.65 $ 882.362  Millions$ 37.302  Millions
89bio Inc   23.25 $ 219.153  Millions$ 9.424  Millions
Rubius Therapeutics inc   22.76 $ 207.904  Millions$ 9.135  Millions
Springworks Therapeutics Inc   21.71 $ 276.819  Millions$ 12.752  Millions
Neoleukin Therapeutics Inc   20.33 $ 201.150  Millions$ 9.892  Millions
Aerpio Pharmaceuticals Inc   19.56 $ 47.282  Millions$ 2.417  Millions
Dyadic International Inc   19.04 $ 30.407  Millions$ 1.597  Millions
Myokardia Inc   17.07 $ 895.879  Millions$ 52.488  Millions
Gossamer Bio Inc   17.03 $ 555.378  Millions$ 32.607  Millions
Scpharmaceuticals Inc   16.94 $ 114.339  Millions$ 6.749  Millions
Celldex Therapeutics Inc   16.36 $ 199.594  Millions$ 12.200  Millions
Crispr Therapeutics Ag  16.23 $ 1,365.990  Millions$ 84.149  Millions
Checkmate Pharmaceuticals Inc   15.50 $ 137.360  Millions$ 8.860  Millions
Capricor Therapeutics Inc   15.50 $ 35.300  Millions$ 2.278  Millions
Casi Pharmaceuticals Inc   13.75 $ 76.388  Millions$ 5.555  Millions
Oxford Immunotec Global Plc  13.61 $ 160.621  Millions$ 11.801  Millions
Royalty Pharma Plc  13.60 $ 2,175.836  Millions$ 159.983  Millions
Igm Biosciences Inc   13.57 $ 180.236  Millions$ 13.282  Millions
Cocrystal Pharma Inc   13.34 $ 31.831  Millions$ 2.386  Millions
Halozyme Therapeutics Inc   12.85 $ 346.706  Millions$ 26.976  Millions
Seneca Biopharma Inc   12.63 $ 12.652  Millions$ 1.002  Millions
Iovance Biotherapeutics inc   12.49 $ 714.148  Millions$ 57.194  Millions
Pds Biotechnology Corp  12.03 $ 33.469  Millions$ 2.782  Millions
Forma Therapeutics Holdings Inc   11.96 $ 366.753  Millions$ 30.666  Millions
Repligen Corp  11.89 $ 553.302  Millions$ 46.524  Millions
Fennec Pharmaceuticals Inc   11.50 $ 33.166  Millions$ 2.885  Millions
Adaptimmune Therapeutics Plc  11.46 $ 399.908  Millions$ 34.899  Millions
Renovacare Inc   11.38 $ 8.671  Millions$ 0.762  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SONO's Profile

Stock Price

SONO's Financials

Business Description

Fundamentals

Charts & Quotes

SONO's News

Suppliers

SONO's Competitors

Customers & Markets

Economic Indicators

SONO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071